Showing results (241-250 of 753) with videos related to
Sort By:
Pageof 76
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's CriteriaMartin J van den Bent, Michael A Vogelbaum, Patrick Y Wen, et al.Journal of Neuro-Oncology|April 18, 2014
The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guidelineJeffrey J Olson, Lakshmi Nayak, D Ryan Ormond, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Facing the future of brain tumor clinical researchMark R Gilbert, Terri S Armstrong, Whitney B Pope, et al.Oncotarget|November 8, 2017
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastomaIsabel Arrillaga-Romany, Andrew S Chi, Joshua E Allen, et al.Neuro-Oncology|January 3, 2018
The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncologyDaniel N Cagney, Joohee Sul, Raymond Y Huang, et al.World Neurosurgery|March 14, 2022
Incidence and Predictors of Neurologic Death in Patients with Brain MetastasesR Alexander Reese, Nayan Lamba, Paul J Catalano, et al.JCO Precision Oncology|February 27, 2023
Validation of Predictive Analyses for Interim Decisions in Clinical TrialsAlejandra Avalos-Pacheco, Steffen Ventz, Andrea Arfè, et al.Neuro-Oncology|July 31, 2022
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumorsRoberta Rudà, David Capper, Adam D Waldman, et al.Neuro-Oncology|February 17, 2010
Bevacizumab salvage therapy following progression in high-grade glioma patients treated with VEGF receptor tyrosine kinase inhibitorsBrian J Scott, Eudocia C Quant, Margaret B McNamara, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Bayesian adaptive randomized trial design for patients with recurrent glioblastomaLorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.Pageof 76